Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Biotricity, Inc. last posted its earnings results on Wednesday, February 19th, 2025. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.06. The company had revenue of 3.62 M for the quarter and had revenue of 12.06 M for the year. Biotricity, Inc. has generated $-2 earnings per share over the last year ($-1.66 diluted earnings per share) and currently has a price-to-earnings ratio of -1.18. Biotricity, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/20/2025 | Q3 2025 | N/A | -$0.05 | N/A | $3.30 M | $3.62 M |
11/14/2024 | Q2 2025 | N/A | -$0.07 | N/A | $3.27 M | $3.27 M |
08/19/2024 | Q1 2025 | N/A | -$0.26 | N/A | $3.20 M | $3.20 M |
06/27/2024 | Q4 2024 | N/A | -$0.44 | N/A | N/A | $3.18 M |
02/20/2024 | Q3 2024 | -$0.41 | -$0.31 | 0.1 | $3.00 M | $2.97 M |
09/29/2023 | Q2 2024 | N/A | -$0.42 | N/A | $3.30 M | $2.89 M |
08/14/2023 | Q1 2024 | -$0.41 | -$0.39 | 0.02 | $3.10 M | $3.02 M |
06/29/2023 | Q4 2023 | -$0.54 | -$0.54 | 0 | N/A | $2.74 M |
02/14/2023 | Q3 2023 | -$0.54 | -$0.52 | 0.02 | N/A | $2.46 M |
11/14/2022 | Q2 2023 | -$0.48 | -$0.54 | -0.06 | $2.54 M | $2.38 M |
08/15/2022 | Q1 2023 | -$0.78 | -$0.56 | 0.22 | $2.19 M | $2.06 M |
07/14/2022 | Q4 2022 | -$0.60 | -$0.70 | -0.1 | N/A | $2.15 M |
02/14/2022 | Q3 2022 | -$0.90 | -$0.87 | 0.03 | N/A | $1.93 M |
11/04/2021 | Q2 2022 | -$0.54 | -$1.50 | -0.96 | $1.81 M | $1.81 M |
08/16/2021 | Q1 2022 | N/A | -$0.87 | N/A | $1.60 M | $1.76 M |
06/21/2021 | Q4 2021 | N/A | -$0.86 | N/A | N/A | $1.19 M |
02/16/2021 | Q3 2021 | N/A | -$0.63 | N/A | N/A | $1.00 M |
11/13/2020 | Q2 2021 | N/A | -$0.48 | N/A | N/A | $744,585 |
08/14/2020 | Q1 2021 | N/A | -$0.52 | N/A | N/A | $451,898 |
07/15/2020 | Q4 2020 | N/A | -$0.76 | N/A | N/A | $362,920 |
Biotricity, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based offlast year's report dates.
In the previous quarter, Biotricity, Inc. (:BTCY) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.06.
The conference call for Biotricity, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Biotricity, Inc.'s latest earnings report can be read online.
Biotricity, Inc. (:BTCY) has a recorded annual revenue of $12.06 M.
Biotricity, Inc. (:BTCY) has a recorded net income of $-14,094,283.Biotricity, Inc. has generated $-1.66 earnings per share over the last four quarters.
Biotricity, Inc. (:BTCY) has a price-to-earnings ratio of -1.18 and price/earnings-to-growth ratio is -0.05.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED